Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeuroKit exploratory study of cortical excitability in healthy volunteers
NL-OMON58295Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of carbamazepine, valproic acid and memantine (4 arms), sponsored by Centre for Human Drug Research. Primary endpoints: EEG-derived cortical excitation/inhibition ratio, Saccadic eye movement and 9 more. Started Jan 2026; status: completed.
02
Drugs
carbamazepinevalproic acidmemantine
Beyond the preview
Go deeper on NL-OMON58295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58295.